지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
초록· 키워드
오류제보하기
Multiple myeloma (MM) is a plasma cell malignancy and is characterized by the presence of lytic bone disease causing severe bone pain, pathological fractures and spinal cord compression. Up to 80% of myeloma patients develop osteolytic lesions during the course of their disease. Appropriate use of imaging techniques is essential in the identification and characterization of the skeletal complications resulting from MM and in determination of the extent of intramedullary bone disease. Despite many weaknesses, conventional radiography still remains the standard for the staging procedure of newly diagnosed and relapsed myeloma patients. Magnetic resonance imaging (MRI) is recommended for MM patients with normal conventional radiography and for all patients with an apparently solitary plasmacytoma of bone. Urgent MRI is the diagnostic procedure of choice to assess suspected cord compression. Although Positron emission tomography/CT (PET/CT) is a useful method to assess the patient's response to the treatment and diagnose the extent of bone involvement and extramedullary disease in the patient, PET/CT is not recommended for routine use in myeloma patients. However, further studies are needed before the recommendation of using PET/CT as a standard tool in both diagnosis and follow-up of MM patients. (Korean J Med 2012;82:686-688)
목차
등록된 정보가 없습니다.
참고문헌 (7)
참고문헌 신청
Bredella MA / 2005 / Value of FDG PET in the assessment of patients with multiple myeloma / AJR Am J Roentgenol 184 : 1199 ~ 1204
D'Sa S / 2007 / Guidelines for the use of imaging in the management of myeloma / Br J Haematol 137 : 49 ~ 63
Durie BG / 2002 / Whole-body (18)F-FDG PET identifies high-risk myeloma / J Nucl Med 43 : 1457 ~ 1463
Haznedar R / 2011 / Value of 18Ffluorodeoxyglucose uptake in positron emission tomography/ computed tomography in predicting survival in multiple myeloma / Eur J Nucl Med Mol
National Comprehensive Cancer Network (NCCN). / / NCCN Clinical Practice Guidelines in Oncology: multiple myeloma [Internet]
D'Sa S / 2007 / Guidelines for the use of imaging in the management of myeloma / Br J Haematol 137 : 49 ~ 63
Durie BG / 2002 / Whole-body (18)F-FDG PET identifies high-risk myeloma / J Nucl Med 43 : 1457 ~ 1463
Haznedar R / 2011 / Value of 18Ffluorodeoxyglucose uptake in positron emission tomography/ computed tomography in predicting survival in multiple myeloma / Eur J Nucl Med Mol
National Comprehensive Cancer Network (NCCN). / / NCCN Clinical Practice Guidelines in Oncology: multiple myeloma [Internet]
이 논문의 저자 정보
최근 본 자료
댓글(0)
0